News & Views | Published:

GUT MICROBIOTA

Precision dietary supplementation based on personal gut microbiota

Nature Reviews Gastroenterology & Hepatology (2019) | Download Citation

Over the past decade, many studies have revealed the importance of the gut microbiome in disease development and treatment, including in cancer. Because both host genetics and the gut microbiome can influence host phenotype and treatment outcome, there is an urgent need to develop precision medicine and personalize dietary supplementation based on an individual’s microbiome.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Singh, V. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175, 679–694 (2018).

  2. 2.

    Koh, A. et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345 (2016).

  3. 3.

    Weitkunat, K. et al. Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice. Sci. Rep. 7, 6109 (2017).

  4. 4.

    Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084–1089 (2015).

  5. 5.

    Chiang, J. Y. L. & Ferrell, J. M. Bile acid metabolism in liver pathobiology. Gene Expr. 18, 71–87 (2018).

  6. 6.

    Jena, P. K. et al. Western diet-induced dysbiosis in farnesoid X receptor knockout mice causes persistent hepatic inflammation after antibiotic treatment. Am. J. Pathol. 187, 1800–1813 (2017).

  7. 7.

    Sheng, L. et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J. Pathol. 243, 431–441 (2017).

  8. 8.

    Belcheva, A. et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158, 288–299 (2014).

  9. 9.

    Tsilimigras, D. I. et al. Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective. Surg. Oncol. 27, 611–618 (2018).

  10. 10.

    Sheng, L. et al. Gender differences in bile acids and microbiota in relationship with gender dissimilarity in steatosis induced by diet and FXR inactivation. Sci. Rep. 7, 1748 (2017).

Download references

Acknowledgements

Y.Y.W. is Professor and Vice Chair for Research in Department of Pathology & Laboratory Medicine at University of California, Davis. This work is supported by grants CA222490 and CA179582 from NCI, NIH. The authors thank Lili Sheng and Julia Ann Wu for their contributions in preparing this manuscript.

Author information

Affiliations

  1. Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA

    • Yu-Jui Yvonne Wan
    •  & Prasant Kumar Jena

Authors

  1. Search for Yu-Jui Yvonne Wan in:

  2. Search for Prasant Kumar Jena in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Yu-Jui Yvonne Wan.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41575-019-0108-z

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing